- FDA
Professional Drug
Information for Tecentriq. N****er NJ,
Gorenberg M,
Agbarya A (November 2020). "First line
Immunotherapy for Non-Small Cell Lung Cancer"...
- ISSN 1538-7933. PMID 16460438. S2CID 5631803. N****er,
Nicola J.; Fox, Jana;
Agbarya, Abed (2020-02-29). "Potential
Mechanisms of Cancer-Related Hypercoagulability"...
- 1086750. ISSN 1744-7631. PMID 26558419. S2CID 207486815. N****er NJ, Fox J,
Agbarya A (March 2020). "Potential
Mechanisms of Cancer-Related Hypercoagulability"...
- 2542–2550. doi:10.1056/nejmoa061884. PMID 17167137. N****er NJ,
Gorenberg M,
Agbarya A (November 2020). "First line
Immunotherapy for Non-Small Cell Lung Cancer"...
-
Immunotherapy for Non-Small Cell Lung Cancer. N****er NJ,
Gorenberg M,
Agbarya A.
Pharmaceuticals 2020, 13(11), 373 https://doi.org/10.3390/ph13110373...
- 2020–2031. doi:10.1056/NEJMoa1910231. PMID 31562796. N****er NJ,
Gorenberg M,
Agbarya A (November 2020). "First line
Immunotherapy for Non-Small Cell Lung Cancer"...
- doi:10.2147/ott.s97746. PMC 5045223. PMID 27713639. N****er NJ,
Gorenberg M,
Agbarya A (November 2020). "First line
Immunotherapy for Non-Small Cell Lung Cancer"...
- 2020–2031. doi:10.1056/NEJMoa1910231. PMID 31562796. N****er NJ,
Gorenberg M,
Agbarya A (November 2020). "First line
Immunotherapy for Non-Small Cell Lung Cancer"...
- {{cite web}}: CS1 maint:
numeric names:
authors list (link)
Gorenberg M,
Agbarya A,
Groshar D,
Volovik I,
Avitan O,
Sukhotnik I.
Novel nanotech antioxidant...
- ISSN 0732-183X. PMID 18506025. N****er,
Nicola J.; Gorenberg, Miguel;
Agbarya, Abed (2020-11-08). "First line
Immunotherapy for Non-Small Cell Lung Cancer"...
